FDA Approved: BROMSITE 0.075% — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for BromSite 0.075% (bromfenac) from Sun Pharmaceutical Industries, likely updating labeling or expanding its use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation
• Postoperative Ocular Pain

Drugs mentioned

• BROMSITE 0.075% (BROMFENAC)

Snippet

SUPPL AP for BROMSITE 0.075% (BROMFENAC)